In another study of stage-related and severity-related biomarkers, they have found CD38 and ZNF595 as significant biomarkers; CD38 can distinguish different clinical stages of dengue, while ZNF595 can differentiate between dengue fever (DF) and DHF [59]. This evidence concerns the gene ZNF595 and Dengue hemorrhagic fever.